Commission signs contract to procure monoclonal antibody therapy against Covid-19
Photo: EPA Commissioner Stella Kyriakides

Commission signs contract to procure monoclonal antibody therapy against Covid-19

At least three new therapeutics will be authorised by October

The European Commission on Tuesday signed a joint procurement framework contract with the pharmaceutical company Glaxo Smith Kline for the supply of sotrovimab (VIR-7831), an investigational monoclonal antibody therapy, developed in collaboration with VIR biotechnology, EC Press service reported on Wednesday. It is part of the first portfolio of five promising therapeutics announced by the Commission in June 2021, and is currently under rolling review by the European Medicines Agency.

50